Evidence map›Paper›PMID 40213570›Full record

ArticleSmall science2024

In-Foam Bioprinting: An Embedded Bioprinting Technique with Self-Removable Support Bath.

Elias Madadian, Hossein Ravanbakhsh, Francesco Touani Kameni, Maedeh Rahimnejad, Sophie Lerouge, Ali Ahmadi

Abstract read
In one paragraph

Article in Small science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elias MadadianDepartment of Mechanical Engineering École de technologie supérieure Montreal H3C 1K3 Canada.ORCID https://orcid.org/0000-0002-1021-9765
Hossein RavanbakhshDepartment of Mechanical Engineering École de technologie supérieure Montreal H3C 1K3 Canada.ORCID https://orcid.org/0000-0001-9518-6378
Francesco Touani KameniBiomaterials and Biofabrication Laboratory Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM) Montreal H2X 0A9 Canada.ORCID https://orcid.org/0000-0002-3976-2438
Maedeh RahimnejadBiomaterials and Biofabrication Laboratory Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM) Montreal H2X 0A9 Canada.ORCID https://orcid.org/0000-0002-2958-1115
Sophie LerougeDepartment of Mechanical Engineering École de technologie supérieure Montreal H3C 1K3 Canada.
Ali AhmadiDepartment of Mechanical Engineering École de technologie supérieure Montreal H3C 1K3 Canada.ORCID https://orcid.org/0000-0003-0498-2235

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of embedded three-dimensional (3D) bioprinting has revolutionized the biofabrication of free-form constructs out of low-viscosity and slow-crosslinking hydrogels. Using gel-based support baths has limitations including lack of proper oxygenation and nutrition and complications with bath removal. Herein, a novel-embedded 3D bioprinting technique is developed with an albumin foam support bath as a promising substitute. The proposed technique, in-foam bioprinting, offers excellent printability and convenience in bath removal while providing cells with easy access to oxygen and nutrients. The foam-based support bath is characterized through foam stability and rheological tests. The bubble size in the foam is measured to study the change in the structure of the bath due to the coalescence of the bubbles over time. Free-form structures are successfully 3D printed with thermoresponsive chitosan-based bioinks to demonstrate the capability of the in-foam bioprinting technique. The viability of bioprinted fibroblast L929 cells is studied over a seven-day period, showing high cell viability of over 97%, which is attributed to the abundance of oxygen and nutrition in the foam support bath. Importantly, in-foam bioprinting is beneficial for biofabricating large samples with a long printing time without jeopardizing cell viability.

Indexed as

albumin foamsbiofabricationchitosan hydrogelembedded bioprintingtissue engineering

Identifiers

PMID40213570
PMCPMC11935082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.